Jin and Juice Investments

Who knew investing could be so much fun =D


leave a comment »

No, I’m not about to give you advice on how to best utilize the goats and cows and your farm. But I am going to try and sell an idea that reduces risk in those questionable times when the market seems extremely volatile. My stock just skyrocketed, and now it has leveled off, so should I sell? Or should I buy some more? What happens after my stock unexpectedly nose-dives? Should I cut my losses, nurse my wounds, and reinvest elsewhere? Or should I stick with it and hope it will rebound?

All of us would like to reduce the risk in our investments. If there was a crash-proof method that ensured that our portfolio would balloon, there would be no questions. Unfortunately, such a method simply does not exist. All we can do, however, is take some educated decisions on how to best reduce the chances of waking up one morning to notice our investment reduced to pennies.

When I first started investing, I always thought in absolute terms. If I bought shares, I bought thousands of the them. If I sold, I sold off everything. But does it have to be this way? Why? When I first invested in Wells Fargo, I but a good chunk of my money in it. When I decided to sell some shares recently after my investment increased by 150%, a nagging thought kept telling me, “It can still go up some more! It can still jump!”

This hesitation is what has cost countless investors millions of dollars over the years. Remember, you’re dealing with the stock market, and the market won’t wait for you to make a decision. I decided to sell off most of my shares in Wells Fargo, but still kept some money in it so that if it does take another leap, then I can still make a decent amount of profit. But if it happens to plummet, then it won’t hurt so much, and at least I can still walk away with hefty gains.

Of course, Wells Fargo isn’t in such a dire situation. I think that this company has proven its resiliency over the past year. But for those of you who are investing in some shares that are a little more shaky, this idea, when applied with a balanced approach, can tip the delicate balance of risk vs. rewards in your favor. You can increase your profit yet cut down your risks by gradually shifting some money out, but still keep some money in that stock in case it jumps up.

How much should you leave in? I base this in the dollar amount that equals the amount of risk I am willing to take on such a company. For example, I recently sold off shares of LJPC because I felt that I made a good amount of profit from that company, but I knew that even though this company doesn’t seem to have an extremely bright future, it might be bought out or merged, which often times makes the shares jump up. I was fully aware that the chance of this happening was slim, so I left $50 in LJPC. Now, if the company crashes, it’s not a big loss for me, but if it happens to jump, then at least I’m still in the game (even if it’s not by much, at least I won’t completely lose out!).

It’s important to keep in mind that this is a juggling game that does require some research and energy, but can help save you from making some terrible mistakes in the long run. After playing with this method for some time, you can develop a sense of how to weigh your risk in terms of dollars, and make more informed, less risky decisions on how much money you should leave in a certain company’s stocks.

As a mild-risk investor, I do my best to not get caught up in the “what ifs” of life, because those “what ifs” will haunt you forever. You can only base your feelings towards your investment on what you currently have, and make educated decisions on what works best for you. I’ve been practicing this method for a few months now, and it has worked wonders for me. Sure, my rewards might seem modest at first, but if you take into account the amount of losses I avoided by using this method, then you can see the advantages of learning how to perfect this method.

-The Sluggy One


Written by jinandjuice2009

May 30, 2009 at 2:02 PM

A Few Things To Remember – XOMA

with 9 comments

Recent Highlights and Developments

 * Completed enrollment in XOMA 052 Phase 1 program in Type 2
   diabetes: Nearly 100 Type 2 diabetes patients were enrolled
   in the Phase 1 trials, which were designed to evaluate a wide
   range of dose levels, single and multiple dose regimens, and
   intravenous and subcutaneous routes of administration. Interim
   results from the single dose intravenous trials, presented in
   September 2008, demonstrated that XOMA 052 was well-tolerated
   across all doses and demonstrated biological activity, including
   reduced levels of glycosylated hemoglobin, increased insulin
   production and decreased levels of C-reactive protein (CRP), a
   marker of cardiovascular risk. These interim results support the
   potential for XOMA 052 as a novel anti-inflammatory approach to
   diabetes treatment and XOMA's plan to initiate a Phase 2 program
   in the third quarter of 2009.

 * Expanded Takeda collaboration, which provided XOMA with a $29
   million fee and potential future milestones and royalties: In
   February 2009, Takeda Pharmaceutical Company Limited (Takeda) and
   XOMA expanded an existing collaboration to provide Takeda with
   access to multiple antibody technologies, including a suite of
   integrated information and data management systems.  XOMA has
   paid $5.8 million of an estimated $7.5 million for taxes and
   other costs related to the expanded collaboration, resulting in
   net cash proceeds received in February 2009 of $23.2 million.

 * Reduced operating costs: XOMA has undertaken multiple cost
   reduction measures that have allowed the company to focus
   research and development spending on the most promising
   proprietary development programs, including XOMA 052 in Type 2
   diabetes. The company expects an annualized reduction of $27
   million in cash expenditures when reductions are completed in
   the current quarter.

Written by jinandjuice2009

May 25, 2009 at 4:00 PM

Comparing VNDA with XOMA

with 4 comments

Today was my mothers Birthday so we went out and had dinner with family.  After having some delicious indian food I couldn’t help but think about what has really been going on with XOMA.  Why have they been so quite lately?  Recently, they had some great news from the FDA, along with raising 10 million financing.  However, their stock prices have dropped considerably which has pissed off many investor driving them to sell and move on.  For some reason every time I think of selling and moving on from XOMA something inside me begs me to give it a second thought.  Being as busy as I am with college finals, a full time job, this website, family, and not having a social life (which also takes a toll on you too) I finally had a chance to consciously address this concern.  I thought it would be fun to compare XOMA with VNDA.  If you have heard about VNDA you already know it has caused a lot of commotion in the past few weeks.  VNDA is the infamous stock that was trading below a $1 on April 29, 2009 and then exploded and now is trading around the $12 to $13 range with a high of $13.08 on Friday May 22, 2009.  Not bad for a month huh!?  Anyways, I started tracing back the events leading up to the big news from VNDA that drove the price up to $13 per share from $1 and surprisingly it mirrors XOMA’s recent activity. 😉

Take a look at VNDA’s SEC Filings & Historical Prices:



Compare to XOMA’s SEC Filing and Historical Prices:



Though some of the SEC Filings may seem meaningless I think it is very important to bare in mind that insiders are buying as much as they can so urgently.  It begs the question, why weren’t they urgently buying when the price was in the $0.30 to $0.50’s range?

The most important question here is  … What do you think?

“…sipping on Gin and Juice, laaaaid back, with my mind on my money and my money on my mind!”

Good luck to ALL

-Jin&Juice =D

Written by jinandjuice2009

May 23, 2009 at 1:15 AM

Xoma – May 21, 2009 Sec Filing

with 2 comments

May 21, 2009


Due to the recent activity of XOMA shooting up to almost $2 per share then to crash all the way back to $0.76 had many investors worried.  This type of activity might cause some to pull the trigger and sell in an attempt to minimize losses.  The fear that drives many investors to this descision is an underlying feeling that they might have been left victims of a pump and dump scheme.   We feel that this on the contrary is and was not a case of pump and dump.  Please bare in mind that this huge jump followed by a huge decline is common for these types of transactions. 

These were the recent SEC filings from XOMA for insider purchases of common shares.  

Good luck to all fellow investors.



Purchases 35,000 Shares


Purchases 35,000Shares


Purchases 45,000 Shares


Purchases 35,000 Shares


Purchases 35000 Shares


Purchases 35000 Shares  


Good luck,


Written by jinandjuice2009

May 22, 2009 at 12:37 AM

XOMA – Feeling like a Bag Holder!?

leave a comment »

XOMA – Feeling like a Bag Holder?

If you bought XOMA high and are pissed off since the price has dropped considerably.  Think about this before you sell and realize huge losses.  Why do big orders keep driving the price up and then small orders for 100 shares keep driving the price down?  This is known as manipulation.  Set to drive prices down that trigger stop losses.

You can follow the trend here on nasdaq:  XOMA Real Time quotes

Also Take a look at the Major Insider Holdings: XOMA Insider Activity

This is a great opportunity to practice patience.   In the the meanwhile go rent:  Boiler Room

Check out:

Written by jinandjuice2009

May 22, 2009 at 12:32 AM

Posted in XOMA

Tagged with